Urobacid

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Urobacid

Urobacid is a synthetic medicine used as a targeted treatment for bacterial infections. It contains the active compound Norfloxacin, which is categorized as a fluoroquinolone antibiotic and works by directly eliminating susceptible bacteria.

Property Description
Active ingredient Norfloxacin (INN)
Form Film-coated tablet
Pharmacological class Fluoroquinolone antibiotic
Common use Anti-bacterial agent
Origin Synthetic (chemically synthesized)

What Type of Medicine is Urobacid?

Urobacid is a synthetic medicinal product whose sole active ingredient is Norfloxacin. It is chemically classified as a fluoroquinolone antibiotic, a key subclass of the broader quinolone antimicrobials. This compound is not naturally derived but is entirely synthetic. Urobacid is typically supplied as a single-ingredient product, formulated into a film-coated tablet for oral administration and is generally designated as a prescription-only medication, reinforcing its targeted use.


Urobacid's General Purpose as an Anti-Infective Agent

The general purpose of Urobacid is to resolve infections by eliminating susceptible pathogenic bacteria through a direct bactericidal process. As a broad-spectrum anti-bacterial agent, it is designed to interfere with vital functions that allow bacteria to thrive and multiply. Norfloxacin is characterized by its effectiveness against a wide range of common aerobic Gram-negative bacteria. The drug is a tool for managing established bacterial infections, often in scenarios requiring systemic intervention. By destroying these pathogens, Urobacid provides a pathway for recovery and resolution of the infection.

What side effects are possible with Urobacid?

Possible Side Effects and Safety Information

The safety profile of Urobacid (Norfloxacin) is structured around potential adverse reactions affecting multiple systems, as classified in official regulatory documents. Side effects are categorized by frequency, which reflects the likelihood of occurrence observed in clinical use.

Frequency-Classified Adverse Reactions

Classification Examples of Documented Effects
Common (1%–10%) Nausea, headache, dizziness, elevated liver enzymes.
Uncommon (0.1%–1%) Abdominal pain, dyspepsia, rash, insomnia, anxiety.
Rare (0.01%–0.1%) Tendon rupture, seizures, crystalluria, severe hypersensitivity reactions.

Serious and Disabling Adverse Reactions

Regulatory authorities highlight the risk of disabling and potentially irreversible serious adverse reactions. These include tendinitis and tendon rupture, particularly of the Achilles tendon, and peripheral neuropathy (numbness, tingling, burning pain, or weakness). Other documented serious effects involve the central nervous system (e.g., seizures), the heart (e.g., QTc interval prolongation and risk of Torsade de Pointes), and the liver, including reports of hepatic failure.

Safety Considerations and Constraints

Certain official safety notes are linked to specific populations or conditions. Older adults and patients using corticosteroids face an increased risk of tendon issues. The label also notes that serious disabling reactions may occur within hours to weeks after starting treatment, and tendon rupture can occur months after discontinuation. Safety limitations include the need for sufficient fluid intake to mitigate the risk of crystalluria and the requirement to avoid excessive sunlight or UV light due to photosensitivity.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Norfloxacin (Urobacid) outlines specific manifestations that may occur following an overdose. Documented clinical presentations include gastrointestinal disturbances such as vomiting, diarrhoea, and gastrointestinal haemorrhage. Central nervous system effects may also be observed, including dizziness, tinnitus, and convulsions (seizures).

In cases classified as significant poisoning, the official documentation specifies the potential for severe systemic outcomes, including acute renal failure and liver damage.


Required Emergency Action

The official regulatory guidance mandates that patients seek immediate medical attention or call a healthcare provider immediately if too much of the medicine is taken. This requirement is absolute across different classifications of exposure, from a potentially toxic to a potentially life-threatening dose.

Regarding management, no specific antidote for Norfloxacin is known. Treatment is consequently symptomatic and supportive. Regulatory labeling notes that procedures such as forced diuresis, dialysis, or haemoperfusion are probably of no help. However, medical professionals may consider administering activated charcoal or performing gastric decontamination for a potentially life-threatening dose. No population-specific overdose severity notes are explicitly documented in official regulatory overdose sections.

Therapeutic Uses of Urobacid

What Urobacid Treats: Main Uses and Benefits

Urobacid (Norfloxacin) is commonly used to help with infections caused by susceptible pathogens, providing support across specific therapeutic domains. The active ingredient Norfloxacin is used in the management of conditions like urinary tract infections (UTIs), certain sexually transmitted diseases, and prostatitis.

The medication is generally applied in contexts marked by increased discomfort or tension, relevant to infections like cystitis, urethritis, and bacterial prostatitis, as well as acute infectious diarrhea and traveler's diarrhea. The therapeutic goal is applied across domains where additional symptomatic support is needed, easing symptoms related to physical discomfort, such as the burning sensation (dysuria) and severe, watery stools.

“The medication helps address symptom clusters that may become intense or disruptive in acute settings.”

Its use is intended to help manage the distressing manifestations of the infection, which contributes to improved comfort by easing distress and assists with maintaining functional stability. Beyond treatment, it is also applied in a preventative role (prophylaxis) for specific high-risk patient populations, such as reducing the risk of Spontaneous Bacterial Peritonitis (SBP) in patients with cirrhosis and ascites.


Quick Fact: Relief for Acute Discomfort
Urobacid is commonly used when short-term symptomatic assistance is needed in scenarios where symptoms intensify, particularly in the urinary and gastrointestinal systems, helping to manage the overall symptom burden.

Regulatory References

  1. According to the U.S. National Institutes of Health (NIH) LiverTox Overview

Eligibility and Restrictions for Use

Official Population Eligibility for Urobacid (Norfloxacin)

Official regulatory documents define strict criteria for who is eligible to use Urobacid, which is a fluoroquinolone class antibiotic. Eligibility is restricted based on medical history, age, and existing physiological conditions.

Eligibility Classification Populations/Conditions
Absolutely Contraindicated (Must not use) • Documented hypersensitivity to Norfloxacin or any other quinolone/fluoroquinolone antibiotic. • History of tendinitis or tendon rupture specifically associated with prior fluoroquinolone use. • Children and growing adolescents (typically under 18 years of age).
Use Not Recommended • Pregnant or breastfeeding women, as use is generally contraindicated or not established due to insufficient data.
Use Requires Caution (Conditional Eligibility) • Patients with impaired renal function (creatinine clearance le 30 mL/min/1.73 m^2). • Individuals with CNS disorders, such as a history of convulsions or epilepsy. • Patients with Myasthenia Gravis, as the drug may exacerbate muscle weakness. • Patients over 60 years of age, organ transplant recipients, or those taking corticosteroids (due to increased risk of tendon problems).

Official regulatory labeling dictates that the safety and efficacy of Norfloxacin are not established in the pediatric population. In older adults, while dosage adjustment is typically not required based on age alone, caution is necessary due to the elevated risk of tendon injury. The restrictions ensure use is confined to populations for whom the drug's risk profile is deemed acceptable by regulatory authorities.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Regulatory documents establish the official interaction profile for Urobacid (Norfloxacin), categorized into pharmacokinetic constraints, pharmacodynamic effects, and mandatory timing rules.

Documented Interaction Patterns

Interaction Type Interacting Substances Official Description
Absorption Interference Antacids (Magnesium/Aluminum), Iron/Zinc Supplements, Meals, Dairy Products Absorption is significantly reduced; requires mandatory timing separation.
Metabolic Inhibition Theophylline, Caffeine, other CYP1A2 Substrates Inhibits the CYP1A2 enzyme, which increases the plasma concentration of the co-administered drug.
Pharmacodynamic Risk Oral Anticoagulants (Warfarin), NSAIDs Enhances the anticoagulant effect of Warfarin; increases the risk of CNS stimulation with NSAIDs.

Official Restrictions and Constraints

Administration must be separated by at least two hours from cation-containing products such as antacids, iron, or zinc supplements to prevent reduced drug exposure. Furthermore, Urobacid should be taken at least one hour before or two hours after meals or dairy products, as ingestion reduces bioavailability. Co-administration with Nitrofurantoin is not recommended due to documented antagonism. The drug may also elevate serum levels of Cyclosporine and its use requires caution in the Elderly or in patients with Hypokalemia due to an increased risk of QTc prolongation.

Mechanism of Action

Urobacid, containing Norfloxacin, functions through a specific and direct bactericidal mechanism targeting the genetic machinery of the pathogen. This action initiates an irreversible mechanism leading to microbial cell death.


Targeting Bacterial Genetic Integrity

The core action of Norfloxacin involves the inhibition of two essential bacterial enzymes: DNA Gyrase (Topoisomerase II) and Topoisomerase IV. These targets are necessary for managing the structure and segregation of bacterial DNA during replication and transcription. By binding to the DNA-enzyme complex, the drug locks the DNA in a cleaved state, which is the molecular event initiating the cytotoxic cascade.


Initiating Irreversible Cell Death

The resulting stabilization of the ternary complex prevents the repair of the DNA, leading to a rapid accumulation of DNA double-strand breaks. This overwhelming damage arrests the cell’s fundamental processes, inhibiting microbial replication and survival. The physiological consequence of this targeted cellular destruction is the direct elimination of susceptible pathogens, leading to the establishment of the Post-Antibiotic Effect (PAE).

Dosage and Administration Information

Instruction Map: How to use Urobacid — Administration Guidelines

Urobacid (Norfloxacin) is a film-coated tablet intended for oral administration. The medication is primarily scheduled for fixed, time-dependent use.


Administration Scope

Instruction Entity Detail
Route of administration Oral (tablet must be swallowed whole with fluid).
Dosing schedule Standard: 400 mg twice daily (maximum 800 mg/day). Single Dose: 800 mg for uncomplicated gonorrhea.
Timing in relation to meals Must be taken on an empty stomach, separated by at least one hour before or two hours after meals, milk, or dairy products.
Dose adjustment rules for impairment For patients with renal impairment (CrCl le 30 mL/min/1.73 m^2), the dose is reduced to 400 mg once daily.
Course Duration Duration is indication-specific: 3 days for select uncomplicated infections, up to 28 days for prostatitis, and 10 to 21 days for complicated urinary tract infections.
Missed-dose rules If a dose is missed, it should be skipped, and the patient should return to the regular schedule; a double dose is not permitted.
Special procedural conditions Patients are instructed to drink fluids liberally to maintain proper hydration. The tablet should not be taken simultaneously with supplements containing minerals (e.g., iron, zinc) or antacids.

Resulting Procedural Structure

Step sequence:

  • Take the 400 mg tablet on an empty stomach.
  • Swallow the tablet whole with a full glass of water.
  • Administer the dose twice daily or once daily if renal function is compromised.

Connection to the overall use protocol The protocol involves a twice-daily frequency for continuous therapy, establishing a fixed rhythm (e.g., every 12 hours) that is dependent on the patient's renal function status. Strict adherence to taking the tablet on an empty stomach and ensuring proper separation from mineral-containing products is required to maintain reliable drug absorption.

Recent Clinical Evidence

Research evidence / Overview of studies for Urobacid

Evidence for Urinary Tract Infections (UTIs)

Urobacid was evaluated in Randomized Controlled Trials (RCTs) and comparative studies examining how symptoms change over time in adults with acute urinary tract infections. Studies monitored whether the compound was associated with symptom changes and whether bacterial presence was observed during the study. Research explored patterns related to infection recurrence in long-term studies up to six months. However, regulatory assessments noted that older trials for complicated infections provided limited insight into these specific cases.


Evidence for Acute Infectious Diarrhea

Research for infectious diarrhea mainly used randomized, double-blind, placebo-controlled trials in populations of adolescents and adults. Studies examined the differences in symptom change compared to groups receiving placebo. Findings apply only to the populations studied and were limited to infections caused by specific susceptible bacteria. Long-term effects are not fully established in this research context.


Evidence for Preventing Spontaneous Bacterial Peritonitis (SBP)

The research for use against SBP was evaluated in double-blind, placebo-controlled RCTs, supported by systematic reviews, in high-risk patients with cirrhosis and ascites. Studies monitored the frequency of SBP recurrence in the groups that received the compound compared to groups that received placebo. These trials monitored patients over defined time intervals, with follow-up durations extending for periods up to one year.


Research Gaps and Remaining Uncertainty

The evidence quality varies across studies, particularly for conditions like chronic prostatitis where available research often consists of smaller, older trials. Comparative evidence is lacking or limited for pediatric patients, and information regarding use in pregnancy-related populations is limited. Furthermore, the increasing global prevalence of bacteria resistant to fluoroquinolones means that findings from older studies may not accurately represent current effectiveness patterns, which is a continuous subject of regulatory review and research.

Frequently Asked Questions (FAQ)

Common questions about Urobacid (FAQ)

Q: How quickly does Urobacid start working after I begin taking it?

Official information regarding how the body handles the medicine (pharmacokinetics) indicates that the highest concentration of the drug in the blood is typically reached within 1 to 2 hours after swallowing a dose. This measurement of concentration does not, however, correspond directly to the exact time a person might feel symptom relief. The speed of symptom change can vary based on the specific type of infection being addressed.

Q: Can Urobacid be used for common colds or is it only for specific infections?

According to the official product information, Urobacid is an antibacterial medicine intended only for infections caused by susceptible bacteria. It is not indicated or effective for conditions like the common cold or flu, which are generally caused by viruses. Its approved uses, as listed in the regulatory documents, include treatment for specific bacterial conditions, such as those related to the urinary tract and certain gastrointestinal issues.

Q: Is Urobacid available over the counter in any country?

In most major regions, Urobacid (Norfloxacin) is generally designated in official labeling as a prescription-only medicine (POM). This designation means that a prescription from a healthcare provider is required to obtain the medication.

Q: Does Urobacid contain sulfa or penicillin?

The active ingredient in Urobacid is Norfloxacin, which belongs to the fluoroquinolone class of antibiotics. Regulatory documents on the composition of the medicine confirm that neither sulfa nor penicillin are listed as active ingredients or components of this product.

Q: Is it normal to feel a mild stomach discomfort when starting Urobacid?

Official documents classify certain gastrointestinal effects, such as nausea and abdominal pain, as commonly reported side effects observed in clinical trials. This type of discomfort may be related to the gastrointestinal effects that are classified as commonly reported side effects in the official safety profile.

Q: Are there any common supplements that are known to interact with Urobacid?

Yes, regulatory documents mention mandatory timing separation from products containing specific minerals, such as iron, zinc, aluminum, or magnesium. Taking the medicine and these minerals too closely in time is associated with a reduction in the drug's absorption.

Q: Can Urobacid change the results of any laboratory blood tests?

Official patient information notes that individuals should inform their healthcare provider they are taking this medicine before any blood tests. This is because the medicine may potentially interfere with the results of some specific tests, leading to inaccurate readings.

Q: Can people who are lactose intolerant take Urobacid?

Regulatory information indicates that some commercial tablet formulations of Urobacid contain inactive ingredients (excipients) like lactose. Verifying the specific excipient list of their prescribed formulation with a pharmacist or healthcare provider may be necessary for individuals with severe lactose intolerance.

Q: Are there any major food groups or drinks to avoid while taking Urobacid?

The official documents specify that the medicine should not be taken too close to milk or other dairy products. A separation time of at least two hours is required because ingestion of dairy can reduce the drug's effectiveness by lowering its absorption.

Q: Does Urobacid have a generic equivalent available?

Since the active compound, Norfloxacin, is no longer protected by patent, various generic equivalents are generally available. These generic medicines contain the same active ingredient and are marketed under different commercial names around the world.

Q: Are there specific symptoms that mean I should stop taking Urobacid immediately?

Official guidance describes conditions where immediate discontinuation of the medicine is noted, such as the appearance of symptoms related to serious adverse reactions. These include pain or swelling in a tendon, signs of nerve issues like tingling or numbness, or signs of a severe allergic reaction such as rash or swelling. The appearance of these serious symptoms is associated with the requirement to contact a healthcare provider for further guidance.

Q: Do official prescribing documents mention any long-term effects of Urobacid use?

Official labels note that some serious and potentially irreversible adverse reactions may manifest over the long term. For example, tendon rupture and nerve damage (peripheral neuropathy) may occur up to several months after a person has stopped taking the medicine.

Q: Is Urobacid known to cause drowsiness or affect driving ability?

Official documents acknowledge that adverse effects like dizziness, headache, or somnolence (drowsiness) have been reported. Because of these potential effects, caution is advised regarding activities that require full alertness, such as driving or operating machinery.

Q: Why are there different brand names for Urobacid globally?

The active ingredient in Urobacid is Norfloxacin. Due to global pharmaceutical marketing rules, different companies have the rights to sell this compound under various commercial brand names in different countries. Therefore, the same medicine may be known by several different names worldwide.

Q: Can Urobacid be used by people with a history of digestive issues?

Official labeling includes warnings about the risk of severe gastrointestinal issues, such as pseudomembranous colitis and pancreatitis. This highlights the necessity for caution and monitoring in patients who have a history of serious bowel disease.

Q: Is Urobacid a medication that requires refrigeration?

No, according to the official storage conditions, Urobacid tablets are required to be kept at room temperature. This temperature is typically defined as 15^circC to 30^circC. The medication should also be protected from direct light and moisture.

Q: How does the described mechanism of action of Urobacid relate to the body's natural defenses?

The regulatory description of Urobacid's action is purely bactericidal, meaning it directly kills susceptible bacteria by damaging their DNA machinery. The official mechanism focuses entirely on the drug's effect on bacterial enzymes and does not describe it as interacting with or enhancing the body's natural immune defenses.

Q: Is the purpose of Urobacid only related to the urinary tract?

No, while the urinary tract is a common area of use, the medicine has other approved purposes. Official indications also include specific uses for infectious diarrhea, chronic bacterial prostatitis, and the prevention of spontaneous bacterial peritonitis (SBP) in certain patients.

Q: Are there specific times of day that are better for taking Urobacid?

Official guidance mandates a fixed twice-daily schedule to maintain consistent drug levels. While the exact time of day may be flexible, separation of the dose from meals, milk, and certain mineral-containing products by mandated time intervals is required to support proper absorption.

Q: What does the patient leaflet say about overdose symptoms for Urobacid?

Official documents advise that if an overdose occurs, general medical measures should be taken, including observing the patient and providing supportive care. However, the specific, detailed symptoms that are expected from an overdose are not fully described in the prescribing information.

Q: Are there any known conflicts between Urobacid and herbal remedies?

Official drug labels generally do not list specific herbal remedies by name. If herbal products contain substances known to interact with Urobacid, such as minerals or CYP1A2 substrates, separation or careful consideration of the interaction profile is noted.

Q: How does Urobacid's action differ from direct pathogen-killing medicines?

Urobacid is, in fact, classified by regulators as a direct pathogen-killing (bactericidal) medicine. Its specific mechanism of action involves irreversibly interfering with the essential bacterial enzymes, DNA Gyrase and Topoisomerase IV, which prevents the bacteria from replicating.

Q: Is it typical to finish the entire course of Urobacid, even if symptoms improve quickly?

Yes, official patient information generally notes that the full prescribed course of therapy should be completed. This instruction stands even if a person feels better or symptoms disappear quickly after starting the medicine.

Q: Does taking Urobacid require any special monitoring by a healthcare provider?

Official documents advise that specific laboratory parameters require close monitoring if the medicine is used alongside certain other prescription drugs, such as oral anticoagulants (e.g., Warfarin). Such co-administration necessitates a healthcare provider checking relevant blood tests.

Q: Are there official registry studies or post-market surveillance reports about Urobacid?

Yes, regulatory agencies continuously collect and monitor post-market data on adverse events and safety concerns, often through official registry studies or pharmacovigilance reports. This information is used to update the official drug labeling and safety warnings.

Q: Can Urobacid be taken alongside other prescription medicines for chronic conditions?

Official documents list specific classes of prescription medicines that are known to interact with Urobacid. This includes blood thinners (oral anticoagulants) and certain pain relievers (NSAIDs). Co-administration with any chronic medication is associated with the need for a healthcare provider to carefully review the full interaction profile.

Q: Is Urobacid the same kind of medicine as other treatments for urinary issues?

Urobacid is a fluoroquinolone antibiotic used to kill susceptible bacteria causing infection. This makes it different from other treatments for urinary issues, such as medicines used only for pain relief (e.g., phenazopyridine) or certain dietary supplements.

Q: Does taking Urobacid affect how birth control pills work?

Urobacid is not categorized in the major class of antibiotics (rifamycin-type) that are primarily known to significantly reduce the effectiveness of hormonal birth control. Reviewing co-medications with a healthcare provider is noted if there are specific concerns.

Q: Can Urobacid be used in older adults (seniors)?

Official guidance indicates that caution is required when the medicine is prescribed to older adults. This population is noted to be at an increased risk for developing severe tendon disorders, especially when they are also taking corticosteroids.

Q: What happens if I accidentally miss a day of taking Urobacid?

The official missed-dose rule is that if a dose is missed, it should be skipped entirely, and the patient should return to their regular schedule for the next dose. Official instructions note that taking a double dose to compensate for a missed one is not permitted.

Q: What is the difference between Urobacid and a standard probiotic?

Urobacid is chemically classified as a synthetic fluoroquinolone antibiotic, designed to eliminate susceptible bacteria that cause infection. In contrast, standard probiotics are defined as live microorganisms intended to promote the balance of beneficial bacteria in the gut.

Q: What does official guidance say about taking Urobacid if I have a known autoimmune condition?

Regulatory warnings specifically advise against the use of the medicine in patients with Myasthenia Gravis, as official data shows it may worsen muscle weakness. The label does not provide specific, official guidance for all other autoimmune conditions.

Q: Why is Urobacid sometimes prescribed for recurring issues?

Official indications for the medicine include its use for prophylaxis, which means prevention. For example, it is approved for preventing the recurrence of spontaneous bacterial peritonitis (SBP) in specific high-risk patients with cirrhosis.

Q: Does Urobacid work for male patients as well as female patients?

Yes, the list of approved indications includes bacterial conditions that affect both sexes, such as uncomplicated urinary tract infections. It also includes conditions specific to male patients, like chronic bacterial prostatitis.

Q: Does Urobacid interact with common cold and flu medications?

Common cold and flu medicines may contain ingredients that are known to interact with Urobacid, such as caffeine or mineral-based additives. Any product containing these substances would require caution or mandatory timing separation from the Urobacid dose.

How should Urobacid be stored and disposed of?

How to Store and Dispose of Urobacid

The storage and disposal of Urobacid (Norfloxacin) must adhere strictly to regulatory guidelines to maintain its quality and ensure safety.


Storage Requirements

Urobacid tablets must be stored at room temperature, typically defined as 15 C to 30 C, and not exceeding 30 C. The product must be kept in a cool dry place and protected from direct light and moisture.

Tablets should remain in their original tightly closed container or blister pack until consumption. A mandatory requirement is to keep the medicine out of reach and sight of children.

Disposal Instructions

Unused or expired Urobacid should not be disposed of in the sink or toilet unless explicitly instructed by the label. The preferred method is using a community drug take-back program or mail-back service. If unavailable, the medicine should be mixed with an undesirable substance (e.g., dirt), sealed in a bag, and discarded in the household trash, with all personal information removed from the label.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Urobacid found in:

A-Z Index: